AAAAAA

   
Results: 1-11 |
Results: 11
ATTENTIONAL DEFICITS IN PARKINSONS-DISEASE - PARTIAL REVERSIBILITY WITH NAPHTOXAZINE (SDZ NVI-085), A SELECTIVE NORADRENERGIC ALPHA(1) AGONIST
Authors: BEDARD MA ELMASSIOUI F MALAPANI C DUBOIS B PILLON B RENAULT B AGID Y
Citation: Ma. Bedard et al., ATTENTIONAL DEFICITS IN PARKINSONS-DISEASE - PARTIAL REVERSIBILITY WITH NAPHTOXAZINE (SDZ NVI-085), A SELECTIVE NORADRENERGIC ALPHA(1) AGONIST, Clinical neuropharmacology, 21(2), 1998, pp. 108-117
RELATIONSHIP BETWEEN THE DEFICIT IN SHARING ATTENTION AND THE DEGREE OF STRIATAL DOPAMINERGIC DENERVATION IN PARKINSONS-DISEASE - A SPECT STUDY USING IODINE-123 BETA-CIT
Authors: DUCHESNE N BEDARD MA SOUCY JP MASSON H
Citation: N. Duchesne et al., RELATIONSHIP BETWEEN THE DEFICIT IN SHARING ATTENTION AND THE DEGREE OF STRIATAL DOPAMINERGIC DENERVATION IN PARKINSONS-DISEASE - A SPECT STUDY USING IODINE-123 BETA-CIT, Neurology, 50(4), 1998, pp. 1105-1105
NORADRENERGIC TREATMENT OF THE FRONTAL SYNDROME IN PARKINSONS-DISEASE- THE EXPERIENCE WITH NAPHTOXAZINE, A SPECIFIC ALPHA-1 RECEPTORS AGONIST
Authors: BEDARD MA LEMAY S ELMASSIOUI F DUBOIS B AGID Y
Citation: Ma. Bedard et al., NORADRENERGIC TREATMENT OF THE FRONTAL SYNDROME IN PARKINSONS-DISEASE- THE EXPERIENCE WITH NAPHTOXAZINE, A SPECIFIC ALPHA-1 RECEPTORS AGONIST, Neurology, 50(4), 1998, pp. 1109-1109
SLEEP AND QUANTITATIVE EEG IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY
Authors: MONTPLAISIR J PETIT D DECARY A MASSON H BEDARD MA PANISSET M REMILLARD G GAUTHIER S
Citation: J. Montplaisir et al., SLEEP AND QUANTITATIVE EEG IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY, Neurology, 49(4), 1997, pp. 999-1003
DIFFERENTIAL-EFFECTS OF D-2-BLOCKING AND D-4-BLOCKING NEUROLEPTICS ONTHE PROCEDURAL LEARNING OF SCHIZOPHRENIC-PATIENTS
Authors: BEDARD MA SCHERER H DELORIMIER J STIP E LALONDE P
Citation: Ma. Bedard et al., DIFFERENTIAL-EFFECTS OF D-2-BLOCKING AND D-4-BLOCKING NEUROLEPTICS ONTHE PROCEDURAL LEARNING OF SCHIZOPHRENIC-PATIENTS, Canadian journal of psychiatry, 41(7), 1996, pp. 21-24
BENZODIAZEPINE-INDUCED AMNESIA - ROLE OF THE SEDATIVE EFFECT
Authors: QUEVILLON F BEDARD MA STIP E
Citation: F. Quevillon et al., BENZODIAZEPINE-INDUCED AMNESIA - ROLE OF THE SEDATIVE EFFECT, Brain and cognition, 32(2), 1996, pp. 326-326
COGNITIVE DECLINE IN YOUNG DRUG-NAIVE SCHIZOPHRENICS
Authors: STIP E LUSSIER I BABAI M DEBRUILLE B BEDARD MA
Citation: E. Stip et al., COGNITIVE DECLINE IN YOUNG DRUG-NAIVE SCHIZOPHRENICS, Schizophrenia research, 15(1-2), 1995, pp. 135-135
COGNITIVE SCIENCE AND NEUROPHARMACOLOGY
Authors: BEDARD MA GODBOUT R
Citation: Ma. Bedard et R. Godbout, COGNITIVE SCIENCE AND NEUROPHARMACOLOGY, MS. Medecine sciences, 11(11), 1995, pp. 1515-1517
NEUROCHEMISTRY OF COGNITIVE FUNCTIONS IN PARKINSONS-DISEASE
Authors: BEDARD MA PANISSET M
Citation: Ma. Bedard et M. Panisset, NEUROCHEMISTRY OF COGNITIVE FUNCTIONS IN PARKINSONS-DISEASE, MS. Medecine sciences, 11(11), 1995, pp. 1541-1549
PERSISTENT NEUROPSYCHOLOGICAL DEFICITS AND VIGILANCE IMPAIRMENT IN SLEEP-APNEA SYNDROME AFTER TREATMENT WITH CONTINUOUS POSITIVE AIRWAYS PRESSURE (CPAP)
Authors: BEDARD MA MONTPLAISIR J MALO J RICHER F ROULEAU I
Citation: Ma. Bedard et al., PERSISTENT NEUROPSYCHOLOGICAL DEFICITS AND VIGILANCE IMPAIRMENT IN SLEEP-APNEA SYNDROME AFTER TREATMENT WITH CONTINUOUS POSITIVE AIRWAYS PRESSURE (CPAP), Journal of clinical and experimental neuropsychology, 15(2), 1993, pp. 330-341
ELECTROPHYSIOLOGY OF PERSEVERATION IN PARKINSONS-DISEASE (PD)
Authors: BEDARD MA ELMASSIOUI F MALAPANI C DUBOIS B RENAULT B AGID Y
Citation: Ma. Bedard et al., ELECTROPHYSIOLOGY OF PERSEVERATION IN PARKINSONS-DISEASE (PD), Neurology, 43(4), 1993, pp. 157-157
Risultati: 1-11 |